Get started
Author

Saurav Verma

Observed names: S Verma, S. Verma, Verma, Saurav; Kalra, Kaushal; Rastogi, Sameer; Dhamija, Ekta; Upadhyay, Avinash; Mittal, Abhenil; Aggarwal, Aditi; Shamim, Shamim Ahmed:
Observed institutions: Western University, Alberta Health Services, Safdarjang Hospital, Vardhman Mahavir Medical College & Safdarjung Hospital, London Health Sciences Centre, Government Medical College and Hospital, DR. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences
ORCID: 0000-0002-8841-9820
Observed ORCID: 0000-0002-8841-9820
OpenAlex ID: A5064332332
Clinical approach to childhood mediastinal tumors and management
2020 · Saurav Verma, Kaushal Kalra, et al. · Mediastinum · 43
Immunotherapy and Radiation Therapy Sequencing in Breast Cancer: A Systematic Review
2024 · Saurav Verma, Sympascho Young, et al. · International Journal of Radiation Oncology*Biology*Physics · 29
An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy
2024 · Saurav Verma, Daniel Breadner, et al. · Cancers · 19
PDF
‘Targeting’ Improved Outcomes with Antibody-Drug Conjugates in Non-Small Cell Lung Cancer—An Updated Review
2023 · Saurav Verma, Daniel Breadner, et al. · Current Oncology · 14
PDF
Neoadjuvant Systemic Chemotherapy in Sebaceous Gland Carcinoma of the Eyelid: A Retrospective Study
2021 · Saurav Verma, Nipun Kumar, et al. · Ocular Oncology and Pathology · 12
A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
2023 · S. Verma, S. Chitikela, et al. · Medical Oncology · 11
Recent Advances in the Management of EGFR-Mutated Advanced Non-Small Cell Lung Cancer—A Narrative Review
2025 · Prabhat Gautam Roy, Davida Reingold, et al. · Current Oncology · 9
A case report of Kaposiform haemangioendothelioma; response with propranolol and steroids
2020 · Saurav Verma, Ekta Dhamija, et al. · Clinical Sarcoma Research · 9
PDF
Utility and safety of maintenance chemotherapy in advanced non–small cell lung cancer across various performance status categories: real-world experience
2020 · Kuruswamy Thurai Prasad, Valliappan Muthu, et al. · Current Problems in Cancer · 9
Efficacy and Toxicity of Combined Inhibition of EGFR and VEGF in Patients With Advanced Non–small Cell Lung Cancer Harboring Activating EGFR Mutations: A Systematic Review and Meta-analysis
2023 · Jasna Deluce, David Maj, et al. · American Journal of Clinical Oncology · 8
Avapritinib in Advanced Gastrointestinal Stromal Tumor: Case Series and Review of the Literature From a Tertiary Care Center in India
2021 · Saurav Verma, Rohit Reddy, et al. · Future Science OA · 8
The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review
2024 · Saurav Verma, Natalie Grindrod, et al. · Cancers · 7
The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer
2023 · Saurav Verma, Sympascho Young, et al. · Therapeutic Advances in Medical Oncology · 7
PDF
Differential effect of body mass index (BMI) on outcomes of patients treated with docetaxel in prostate cancer - An exploratory analysis.
2022 · Saurav Verma, Shalabh Arora, et al. · Cancer Treatment and Research Communications · 7
PDF
Evaluation of HER2 immunohistochemistry expression in non-standard solid tumors from a Single-Institution Prospective Cohort
2024 · Saurav Verma, Amanda Chapman, et al. · Exploration of Targeted Anti-tumor Therapy · 6
PDF
Partial response to erlotinib in a patient with imatinib-refractory sacral chordoma
2020 · Saurav Verma, Surya Prakash Vadlamani, et al. · Clinical Sarcoma Research · 6
PDF
Circulating tumor DNA as part of the routine work-up for patients with suspected advanced lung cancer
2025 · Emma Holjak, Tia Brasoveanu, et al. · The Journal of Liquid Biopsy · 4
PDF
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors (SABR-DETECT)
2023 · Saurav Verma, Sympascho Young, et al. · Clinical Lung Cancer · 4
PDF
Assessing clinician performance using a multi-modality clinical decision-support system for lung cancer prognostication
2025 · Jaryd R. Christie, Karen Eddy, et al. · Scientific Reports · 3
PDF
The TROP2 paradox: enhancing precision in immunotherapy for advanced non-small cell lung cancer patients—a commentary
2025 · Saqib Raza Khan, Saurav Verma, et al. · Translational Cancer Research · 3
1327P First-line osimertinib in patients with EGFR mutated lung cancer with uncommon mutations (OCELOT study – interim analysis)
2023 · D.A. Breadner, G. Liu, et al. · Annals of Oncology · 3
PDF
Impact of Oncology Drug Review Times on Public Funding Recommendations
2023 · Marya Hussain, Chelsea Wong, et al. · Current Oncology · 3
PDF
Survival of Persons Living With HIV/AIDS: A Multicentric Study From India
2023 · Sanjeev Sinha, Sameer Abdul Samad, et al. · Current HIV Research · 3
Raltitrexed as a substitute for 5-fluorouracil in combination with pembrolizumab and platinum in a patient with metastatic esophageal squamous cell carcinoma and coronary artery disease: a case report
2025 · Matthew Van Oirschot, Saurav Verma, et al. · Annals of Translational Medicine · 1
The optimum balance between efficacy and toxicity with different doses of trastuzumab deruxtecan in HER2 mutated non-small cell lung cancer in DESTINY-Lung02 trial
2024 · Saurav Verma, Jacques Raphael · AME Clinical Trials Review · 1
Works count: 45
Citation count: 232
H-index: 9
I10-index: 6
Year
Topic
Type